Product Price :Get Latest PriceProduct Details:
|Brand Name||DEVCEF 1000|
|Manufacturer||DEVLIFE CORPORATION PVT. LTD.|
|Injection Site||IV & IM|
|Dosage||As directed by the physician.|
|Composition||Each vial contains:|
|Also gives||Third Party Manufacturing|
|Packaging Type||Glass Ampoules|
|Shelf life||2 Years|
|Country of Origin||Made in India|
Each vial contains:
Ceftriaxone Sodium USP
Eq. to Ceftriaxone .. 1g
J01DA13 - Cephalosporins and related substances.
Pharmacodynamic effects : Ceftriaxone exerts in vitro activity against a wide range of Gram-negative and Gram-positive microorganisms. Ceftriaxone is highly stable to most beta-lactamases, both the penicillinases and cephalosporinases, of Gram-positive and Gram-negative bacteria.
Antibiotic class : Long acting, broad spectrum semi-synthetic cephalosporin for intramuscular or intravenous administration.
Antibiotic nature and mode of action : The bactericidal activity of ceftriaxone results from inhibition of bacterial cell wall synthesis.
Indications: Infections caused by pathogens sensitive to Ceftriaxone Injection, e.g.: sepsis; meningitis; abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); infections of the bones, joints, soft tissue, skin and of wounds; infections in patients with impaired defence mechanisms; renal and urinary tract infections; respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; genital infections, including gonorrhoea. Perioperative prophylaxis of infections.
- Infections caused by pathogens sensitive to Ceftriaxone Injection (sepsis, meningitis)
-infections of the bones, joints, soft tissue, skin and of wounds
-renal and urinary tract infections
-respiratory tract infections
-pneumonia, and ear, nose and throat infections
Explore More Products